Publicaciones en colaboración con investigadores/as de Universidad Austral (9)

2021

  1. SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism

    Liver International, Vol. 41, Núm. 7, pp. 1677-1693

2019

  1. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets

    Journal of Hepatology, Vol. 71, Núm. 1, pp. 78-90

2015

  1. Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-/-IL2Rγnull immunodeficient mice

    Cancer Research, Vol. 75, Núm. 17, pp. 3466-3478

2014

  1. Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins

    Clinical Cancer Research, Vol. 20, Núm. 22, pp. 5697-5707

2013

  1. Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein

    Cancer Research, Vol. 73, Núm. 1, pp. 139-149

  2. Interleukin-15 in gene therapy of cancer

    Current Gene Therapy, Vol. 13, Núm. 1, pp. 15-30

2012

  1. The liver, liver metastasis and liver cancer: A special case for immunotherapy with cytokines and immunostimulatory monoclonal antibodies

    Immunotherapy, Vol. 4, Núm. 11, pp. 1081-1085

2011

  1. Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma

    Cancer Immunology, Immunotherapy, Vol. 60, Núm. 10, pp. 1383-1395

2007

  1. Immunotherapy and immunoescape in colorectal cancer

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5822-5831